Medical specialties

The Worldwide Market for Anesthesia Devices, 2019 to 2023 - Rise in Demand for Disposable Anesthesia Devices

Retrieved on: 
Monday, May 13, 2019

DUBLIN, May 13, 2019 /PRNewswire/ --The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 13, 2019 /PRNewswire/ --The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The anaesthesia devices market will register a CAGR of over 6% by 2023.
  • The increasing number of surgeries requiring general anaesthesia is one of the key factors expected to trigger the anaesthesia devices market growth during the forecast period.
  • General anaesthesia is administered to the patients by medical practitioners for inducing unconsciousness during surgery and for post-surgery pain management.

The Academy recognizes 14 health stories with a 2019 Media Orthopaedic Reporting Excellence (MORE) Award

Retrieved on: 
Monday, May 13, 2019

ROSEMONT, Ill., May 13, 2019 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced 14 recipients of the 2019 MORE Awards presented annually to journalists for accurate reporting of bone and joint health news topics.

Key Points: 
  • ROSEMONT, Ill., May 13, 2019 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced 14 recipients of the 2019 MORE Awards presented annually to journalists for accurate reporting of bone and joint health news topics.
  • The winners of the 2019 awards include health and medical writers, producers and freelance reporters from print, broadcast and online media outlets.
  • Their stories covered an array of orthopaedic topics, bringing patient stories to life and highlighting orthopaedic innovation and treatment options.
  • "Members of the media are key influencers in how the public perceives musculoskeletal health," said AAOS President Kristy L. Weber, MD.

IQuity Research Unveils Potential $18 Billion in Health Plan Cost-Savings and Demonstrates Effectiveness of Identifying At-Risk Autoimmune Disease Patients

Retrieved on: 
Monday, May 13, 2019

These six conditions alone affect approximately 60 million people at an estimated cost to diagnose and treat of $90B annually.

Key Points: 
  • These six conditions alone affect approximately 60 million people at an estimated cost to diagnose and treat of $90B annually.
  • "Almost everyone knows someone who is affected by an autoimmune disease or related syndrome," said Chase Spurlock , PhD, CEO at IQuity.
  • "Most people don't understand what an autoimmune disease is or the impact these conditions have on patients and the overall healthcare system.
  • As evidenced by the research findings, the impact autoimmune diseases pose to U.S. healthcare spending is severe.

Bispecific Antibodies for Cancer: Worldwide Market Analysis & Outlook Report, 2019 to 2023 - ResearchAndMarkets.com

Retrieved on: 
Monday, May 13, 2019

The bispecific antibodies for cancer market will register a CAGR of over 30% by 2023.

Key Points: 
  • The bispecific antibodies for cancer market will register a CAGR of over 30% by 2023.
  • The advantages of bispecific antibodies over monoclonal antibodies is one of the key factors expected to propel the market growth during the forecast period.
  • Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.
  • Hence, the advantages of bispecific antibodies will drive the growth of the market in the upcoming years.

California Leaders in Science and Policy Discuss Impacts of Sickle Cell Disease

Retrieved on: 
Monday, May 13, 2019

California adults with sickle cell disease die at younger ages, at higher rates, and have a higher rate of emergency room visits and hospitalizations compared to sickle cell disease patients in other states.

Key Points: 
  • California adults with sickle cell disease die at younger ages, at higher rates, and have a higher rate of emergency room visits and hospitalizations compared to sickle cell disease patients in other states.
  • With a growing population of individuals with sickle cell disease and sickle cell trait, the primary focus of the SCDF is to educate, screen and counsel those persons at risk of having children with sickle cell disease and other hemoglobin disorders.
  • CIBD is the recipient of the HRSA Sickle Cell Disease Treatment and Demonstration Program provided by the Pacific Sickle Cell Regional Collaborative.
  • CIBD was also the host of a stakeholder meeting at the University of California, Davis campus to discuss the State Action Plan for sickle cell disease.

InventHelp Inventor Develops Urinary Incontinence Product for Men (HUN-726)

Retrieved on: 
Monday, May 13, 2019

PITTSBURGH, May 13, 2019 /PRNewswire/ -- "I wanted to create a simple way to help men with urinary incontinence," said an inventor, from Cypress, Texas, "so I invented PEACE OF MIND."

Key Points: 
  • PITTSBURGH, May 13, 2019 /PRNewswire/ -- "I wanted to create a simple way to help men with urinary incontinence," said an inventor, from Cypress, Texas, "so I invented PEACE OF MIND."
  • The patent pending invention provides added protection and peace of mind for men who experience urinary incontinence.
  • In doing so, it offers an alternative to traditional catheters, protective underwear and incontinence products.
  • The invention features a discreet design that is convenient and easy to use so it is ideal for men who experience urinary incontinence.

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Retrieved on: 
Monday, May 13, 2019

Abiomed(NASDAQ:ABMD) announces the U.S. FDA has approved the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic shock.

Key Points: 
  • Abiomed(NASDAQ:ABMD) announces the U.S. FDA has approved the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic shock.
  • The Impella 5.0 is implanted through the femoral or axillary artery and the Impella LD is implanted directly into the aorta.
  • View the full release here: https://www.businesswire.com/news/home/20190513005623/en/
    Erin Hanussak, then 33 years old, suffered from myocarditis and went into cardiogenic shock.
  • TheAbiomedlogo,Abiomed, Impella, Impella 2.5, Impella 5.0, Impella LD, Impella CP, Impella RP, Impella Connect, and Recovering hearts.

Physician-researcher named a distinguished fellow by American Association of Immunologists

Retrieved on: 
Monday, May 13, 2019

MANHASSET, N.Y., May 13, 2019 /PRNewswire/ -- The American Association of Immunologists (AAI) has named Betty Diamond, MD , professor at The Feinstein Institute for Medical Research , to its inaugural class of distinguished fellows.

Key Points: 
  • MANHASSET, N.Y., May 13, 2019 /PRNewswire/ -- The American Association of Immunologists (AAI) has named Betty Diamond, MD , professor at The Feinstein Institute for Medical Research , to its inaugural class of distinguished fellows.
  • Dr. Diamond, an autoimmune disease expert and lupus researcher, has served as an AAI member since 1980, and was president of the association from 2009-2010.
  • Election as a Distinguished Fellow will now occur annually and is among the highest honors bestowed by AAI.
  • Today, as the most prestigious association of immunologists in the world, AAI continues to champion the interests of its membership, which has grown to nearly 8,000 scientists in 71 countries.

Hospitals Improving Patient Safety by Bridging the Gap Between IT and Biomedical Departments

Retrieved on: 
Monday, May 13, 2019

Hospitals in Canada are supporting these networks with ongoing interdepartmental communication, clear departmental responsibilities, and a regular preventive maintenance schedule.

Key Points: 
  • Hospitals in Canada are supporting these networks with ongoing interdepartmental communication, clear departmental responsibilities, and a regular preventive maintenance schedule.
  • Frost & Sullivan's virtual think tank,Best Practices for Managing Patient Monitoring Networks Across the IT and Biomedical Departments, aims to understand what best practices successful hospitals were following to keep these critical pieces of infrastructure functional and focused on supporting patient care.
  • Half of respondents reported the biomedical department was responsible for maintaining medical device assets and that the patient monitoring networks fell under a shared responsibility with clinical IT departments.
  • "Breaking down silos between the biomedical and IT departments is a critical step in reducing the risk of patient monitoring network outages."

Excel Physical Therapy Expands into Essex County

Retrieved on: 
Monday, May 13, 2019

LIVINGSTON, N.J., May 13, 2019 /PRNewswire-PRWeb/ -- Excel Orthopedic Physical Therapy ("EXCEL"), New Jersey's premier provider of orthopedic physical therapy since 1990, last week opened an office at 555 S Livingston Avenue at the former site of historic Livingston retailer Sams Fine Men's Clothing ("Sams").

Key Points: 
  • LIVINGSTON, N.J., May 13, 2019 /PRNewswire-PRWeb/ -- Excel Orthopedic Physical Therapy ("EXCEL"), New Jersey's premier provider of orthopedic physical therapy since 1990, last week opened an office at 555 S Livingston Avenue at the former site of historic Livingston retailer Sams Fine Men's Clothing ("Sams").
  • At 6,200-square feet on the main level, Livingston is the largest of the company's fifteen offices located throughout Essex, Union, Bergen, and Hudson counties.
  • We feel that EXCEL's entrance into Essex County will mesh with the fabric of the community.
  • EXCEL Orthopedic Physical Therapy specializes in the provision of comprehensive physical therapy to individuals following joint replacement, arthroscopic and reconstructive surgeries, as well as spine surgeries.